— Know what they know.
Not Investment Advice
Also trades as: 4521.T (JPX) · $vol 3M

KKPCF Earnings

Kaken Pharmaceutical Co., Ltd.
1W: +0.0% 1M: -2.4% 3M: -2.4% YTD: +7.4% 1Y: -7.5% 3Y: -6.0% 5Y: -26.6%
$26.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 46 · $984.6M mcap · 23M float · 0.0000% daily turnover · Short 100% of daily vol
Last Earnings 2026-08-07
EPS
¥1.37 (US$0.01)
▲ Beat +0.0%
Revenue
¥185M ($1M)
▼ Miss -0.2%
Next Earnings 2026-11-05
1 USD = 157.83 JPY

Estimate vs Actual

Earnings Surprise History

0/19
EPS Beats
0/19
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2027-03-31 ¥146.32 ¥146.25 ▼ 0.07 ¥87,055,026,034 ¥87,013,936,500
2026-10-02 annual 2031-03-31 ¥156.60 ¥156.53 ▼ 0.07 ¥80,607,139,037 ¥80,569,092,873
2026-10-02 annual 2030-03-31 ¥81.04 ¥81.00 ▼ 0.04 ¥77,220,715,627 ¥77,184,267,839
2026-10-02 annual 2029-03-31 ¥74.60 ¥74.57 ▼ 0.03 ¥83,942,253,001 ¥83,902,632,680
2026-10-02 annual 2028-03-31 ¥98.01 ¥97.97 ▼ 0.04 ¥84,215,903,378 ¥84,176,153,896
2026-10-01 annual 2031-03-31 ¥156.45 ¥156.60 ▲ 0.15 ¥80,531,046,709 ¥80,607,139,037
2026-10-01 annual 2030-03-31 ¥80.97 ¥81.04 ▲ 0.07 ¥77,147,820,050 ¥77,220,715,627
2026-10-01 annual 2028-03-31 ¥97.92 ¥98.01 ▲ 0.09 ¥84,136,404,413 ¥84,215,903,378
2026-10-01 annual 2027-03-31 ¥146.18 ¥146.32 ▲ 0.14 ¥86,972,846,966 ¥87,055,026,034
2026-10-01 annual 2029-03-31 ¥74.53 ¥74.60 ▲ 0.07 ¥83,863,012,359 ¥83,942,253,001
2026-09-30 annual 2028-03-31 ¥98.01 ¥97.92 ▼ 0.09 ¥84,215,903,378 ¥84,136,404,413
2026-09-30 annual 2029-03-31 ¥74.60 ¥74.53 ▼ 0.07 ¥83,942,253,001 ¥83,863,012,359
2026-09-30 annual 2027-03-31 ¥146.32 ¥146.18 ▼ 0.14 ¥87,055,026,034 ¥86,972,846,966
2026-09-30 annual 2031-03-31 ¥156.60 ¥156.45 ▼ 0.15 ¥80,607,139,037 ¥80,531,046,709
2026-09-30 annual 2030-03-31 ¥81.04 ¥80.97 ▼ 0.07 ¥77,220,715,627 ¥77,147,820,050
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms